Timolol maleate is a beta1 and beta2 (non-selective) adrenergic receptor blocking agent. Applied in the eye it acts by reducing elevated as well as normal intraocular pressure, whether or not accompanied by glaucoma. The precise mechanism of the ocular hypotensive action of Timoptic is not clearly established at this time.
Timolol maleate is a beta1 and beta2 (non-selective) adrenergic receptor blocking agent. Applied in the eye it acts by reducing elevated as well as normal intraocular pressure, whether or not accompanied by glaucoma. The precise mechanism of the ocular hypotensive action of Timoptic is not clearly established at this time.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
Timolol maleate is a beta1 and beta2 (non-selective) adrenergic receptor blocking agent. Applied in the eye it acts by reducing elevated as well as normal intraocular pressure, whether or not accompanied by glaucoma. The precise mechanism of the ocular hypotensive action of Timoptic is not clearly established at this time.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
Elisabeth Fandrich NURS 2516 Clinical Medications Worksheets (You will need to make additional copies of these forms)
Generic Name Trade Name Classification Dose Route Time/frequency
timolol Timoptic Beta blocker 0.5% (1 drop) OD 2100 q HS maleate Peak Onset Duration For IV meds, compatibility with IV drips and /or solutions 1-2 hrs Within ½ hr Up to 24 hrs
Mechanism of action and indications Nursing Implications (what to focus on)
(Why med ordered) Contraindications/warnings/interactions Timolol maleate is a beta1 and beta2 (non-selective) Timoptic is contraindicated in patients with (1) bronchial adrenergic receptor blocking agent that does not have asthma; (2) a history of bronchial asthma; (3) severe chronic significant intrinsic sympathomimetic, direct myocardial obstructive pulmonary disease; (4) sinus bradycardia; depressant, or local anesthetic (membrane-stabilizing) (5) second or third degree atrioventricular block; (6) overt activity. Applied in the eye it acts by reducing elevated cardiac failure; (7) cardiogenic shock; or (8) hypersensitivity as well as normal intraocular pressure, whether or not to any component of this product. No overall differences in accompanied by glaucoma. Elevated intraocular pressure safety or effectiveness have been observed between elderly is a major risk factor in the pathogenesis of glaucomatous and younger patients. visual field loss. The higher the level of intraocular Common side effects pressure, the greater the likelihood of glaucomatous The most frequently reported adverse experiences have been visual field loss and optic nerve damage. The precise burning and stinging upon instillation (approximately one in mechanism of the ocular hypotensive action of Timoptic eight patients). Slight reduction of resting heart rate in some is not clearly established at this time. Tonography and patients fluorophotometry studies in man suggest that its The same adverse reactions found with systemic predominant action may be related to reduced aqueous administration of beta-adrenergic blocking agents may occur formation. However, in some studies a slight increase in with topical administration. For example, severe respiratory outflow facility was also observed. reactions and cardiac reactions, including death due to Glaucoma (open-angle) bronchospasm in patients with asthma, and rarely death in association with cardiac failure, have been reported following systemic or ophthalmic administration of timolol maleate. Fatigue, weakness Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine medicines (ask patient specifically) May cause ↑ BUN, serum lipoprotein, potassium, None for this patient triglyceride, and uric acid levels May cause ↑ ANA titers May cause ↑ in blood glucose levels
Be sure to teach the patient the following about this
medication Avoid allowing the tip of the dispensing container to contact the eye or surrounding structures. Ocular solutions, if handled improperly or if the tip of the dispensing container contacts the eye or surrounding structures, can become contaminated by common bacteria 2 Elisabeth Fandrich known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions. If they have ocular surgery or develop an intercurrent ocular condition (e.g., trauma or infection), they should immediately seek their physician's advice concerning the continued use of the present multidose container. Patients with bronchial asthma, a history of bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second or third degree atrioventricular block, or cardiac failure should be advised not to take this product.
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this Check after giving Monitor blood pressure and pulse frequently med? Because of diurnal variations during dose adjustment period and If signs or symptoms suggesting in intraocular pressure, periodically during therapy. Assess for reduced cerebral blood flow develop. satisfactory response to the orthostatic hypotension when assisting patient once-a-day dose is best up from supine position determined by measuring the intraocular pressure at different times during the day.